
Our patented technology uses polarized light and our image processing algorithms to accentuate the size, shape, and location and identify retinal protein deposits seen in brain diseases.
AI-assisted differential analysis determines the type of protein deposit, the associated disease, and the degree of severity.

Our technology detects
Amyloid Beta
Alpha-Synuclein
TDP-43
Drusen
Retinal Blood Vessel Health